About
Contact & Profiles
A5037405595
Research Areas
- Pharmaceutical Practices and Patient Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Hip and Femur Fractures
- Intensive Care Unit Cognitive Disorders
- Dementia and Cognitive Impairment Research
- Bone fractures and treatments
- Geriatric Care and Nursing Homes
- Trauma and Emergency Care Studies
- Pharmacovigilance and Adverse Drug Reactions
Istituto Nazionale di Riposo e Cura per Anziani
2020-2021
Istituti di Ricovero e Cura a Carattere Scientifico
2021
Multi-morbidity and polypharmacy increase the risk of non-trivial adverse drug reactions (ADRs) in older people during hospitalization. Despite this, there are no established interventions for hospital-acquired ADR prevention.We undertook a pragmatic, multi-national, parallel arm prospective randomized open-label, blinded endpoint (PROBE) controlled trial enrolling patients at six European medical centres. We 1,537 surgical with multi-morbidity on admission 1:1 ratio to SENATOR...
10.1093/ageing/afaa072
article
EN
Age and Ageing
2020-03-31
10.1016/j.jamda.2021.02.029
article
EN
Journal of the American Medical Directors Association
2021-04-03
Coming Soon ...